412
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Novel bioengineered MBenes for the treatment of Alzheimer's disease: An in-Sillico study

, , , , , & show all
Pages 12268-12276 | Received 17 Apr 2021, Accepted 12 Aug 2021, Published online: 24 Aug 2021

References

  • Abedi, M., Abolmaali, S. S., Abedanzadeh, M., Borandeh, S., Samani, S. M., & Tamaddon, A. M. (2019). Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe3O4/carboxyl functionalized mesoporous SiO2 hybrid nanoparticles: A-synthesis, physicochemical and biological characterization. Materials Science and Engineering: C, 104, 109922.
  • Akbarialiabad, H., Dahroud, M. D., Khazaei, M. M., Razmeh, S., & Zarshenas, M. M. (2021). Green tea, a medicinal food with promising neurological benefits. Current Neuropharmacology, 19(3), 349–359. https://doi.org/10.2174/1570159X18666200529152625
  • Alimohammadi, E., Maleki, R., Akbarialiabad, H., & Dahri, M. (2021). Novel pH-responsive nanohybrid for simultaneous delivery of doxorubicin and paclitaxel: An in-silico insight. BMC Chemistry, 15(1), 1–11. https://doi.org/10.1186/s13065-021-00735-4
  • Alimohammadi, E., Nikzad, A., Khedri, M., Rezaian, M., Jahromi, A. M., Rezaei, N., & Maleki, R. (2021). Potential treatment of Parkinson’s disease using new-generation carbon nanotubes: A biomolecular in silico study. Nanomedicine (London, England), 16(3), 189–204. https://doi.org/10.2217/nnm-2020-0372
  • Atri, A., Frölich, L., Ballard, C., Tariot, P. N., Molinuevo, J. L., Boneva, N., Windfeld, K., Raket, L. L., & Cummings, J. L. (2018). Effect of idalopirdine as adjunct to cholinesterase inhibitors on change in cognition in patients with Alzheimer disease: Three randomized clinical trials. JAMA, 319(2), 130–142. https://doi.org/10.1001/jama.2017.20373
  • Beck, D. A., & Daggett, V. (2004). Methods for molecular dynamics simulations of protein folding/unfolding in solution. Methods (San Diego, Calif.), 34(1), 112–120. https://doi.org/10.1016/j.ymeth.2004.03.008
  • Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010). EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity . Proceedings of the National Academy of Sciences of the United States of America, 107(17), 7710–7715. https://doi.org/10.1073/pnas.0910723107
  • Chen, Z., Krause, G., & Reif, B. (2005). Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils. Journal of Molecular Biology, 354(4), 760–776. https://doi.org/10.1016/j.jmb.2005.09.055
  • Chen, Y., Wang, L., & Shi, J. (2016). Two-dimensional non-carbonaceous materials-enabled efficient photothermal cancer therapy. Nano Today, 11(3), 292–308. https://doi.org/10.1016/j.nantod.2016.05.009
  • Chimene, D., Alge, D. L., & Gaharwar, A. K. (2015). Two-dimensional nanomaterials for biomedical applications: Emerging trends and future prospects . Advanced Materials (Deerfield Beach, Fla.), 27(45), 7261–7284. https://doi.org/10.1002/adma.201502422
  • Chiti, F., & Dobson, C. M. (2006). Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry, 75, 333–366. https://doi.org/10.1146/annurev.biochem.75.101304.123901
  • Coric, V., Salloway, S., van Dyck, C. H., Dubois, B., Andreasen, N., Brody, M., Curtis, C., Soininen, H., Thein, S., Shiovitz, T., Pilcher, G., Ferris, S., Colby, S., Kerselaers, W., Dockens, R., Soares, H., Kaplita, S., Luo, F., Pachai, C., … Berman, R. M. (2015). Targeting prodromal Alzheimer disease with avagacestat: A randomized clinical trial. JAMA Neurology, 72(11), 1324–1333. https://doi.org/10.1001/jamaneurol.2015.0607
  • da Silva, J. A., Meneghetti, M. R., & Netz, P. A. (2020). Molecular dynamics simulations of the structural arrangement and density of alkylamine surfactants on copper surfaces: Implications for anisotropic growth of copper nanowires. ACS Applied Nano Materials, 3(6), 5343–5350. https://doi.org/10.1021/acsanm.0c00708
  • DeVos, S. L., Corjuc, B. T., Commins, C., Dujardin, S., Bannon, R. N., Corjuc, D., Moore, B. D., Bennett, R. E., Jorfi, M., Gonzales, J. A., Dooley, P. M., Roe, A. D., Pitstick, R., Irimia, D., Frosch, M. P., Carlson, G. A., & Hyman, B. T. (2018). Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo. Brain : A Journal of Neurology, 141(7), 2194–2212. https://doi.org/10.1093/brain/awy117
  • Dhayabaran, D., Florance, E. J., Nandakumar, K., Shanmugarathinam, A., & Puratchikody, A. (2014). Anticonvulsant activity of fraction isolated from ethanolic extract of heartwood of Cedrus deodara. Journal of Natural Medicines, 68(2), 310–315. https://doi.org/10.1007/s11418-013-0798-4
  • Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., & Mohs, R. (2014). Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. The New England Journal of Medicine, 370(4), 311–321. https://doi.org/10.1056/NEJMoa1312889
  • Egan, M. F., Kost, J., Tariot, P. N., Aisen, P. S., Cummings, J. L., Vellas, B., Sur, C., Mukai, Y., Voss, T., Furtek, C., Mahoney, E., Harper Mozley, L., Vandenberghe, R., Mo, Y., & Michelson, D. (2018). Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease. The New England Journal of Medicine, 378(18), 1691–1703. https://doi.org/10.1056/NEJMoa1706441
  • Estrada, L., & Soto, C. (2007). Disrupting beta-amyloid aggregation for Alzheimer disease treatment . Current Topics in Medicinal Chemistry, 7(1), 115–126. https://doi.org/10.2174/156802607779318262
  • Hajipour, M. J., Santoso, M. R., Rezaee, F., Aghaverdi, H., Mahmoudi, M., & Perry, G. (2017). Advances in Alzheimer's diagnosis and therapy: The implications of nanotechnology. Trends in Biotechnology, 35(10), 937–953. https://doi.org/10.1016/j.tibtech.2017.06.002
  • Hanwell, M. D., Curtis, D. E., Lonie, D. C., Vandermeersch, T., Zurek, E., & Hutchison, G. R. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(1), 1–17. https://doi.org/10.1186/1758-2946-4-17
  • Harrington, C. R. (2012). The molecular pathology of Alzheimer's disease. Neuroimaging Clinics of North America, 22(1), 11–22. https://doi.org/10.1016/j.nic.2011.11.003
  • Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143. https://doi.org/10.1016/j.neuron.2018.08.011
  • Karlawish, J., & Grill, J. D. (2021). The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA. Nature Reviews Neurology, 1–2.
  • Kaushik, A. C., & Sahi, S. (2017). Molecular modeling and molecular dynamics simulation-based structural analysis of GPR3. Network Modeling Analysis in Health Informatics and Bioinformatics, 6(1), 9. https://doi.org/10.1007/s13721-017-0150-0
  • Kühne, T. D., Iannuzzi, M., Del Ben, M., Rybkin, V. V., Seewald, P., Stein, F., Laino, T., Khaliullin, R. Z., Schütt, O., Schiffmann, F., Golze, D., Wilhelm, J., Chulkov, S., Bani-Hashemian, M. H., Weber, V., Borštnik, U., Taillefumier, M., Jakobovits, A. S., Lazzaro, A., … Hutter, J. (2020). CP2K: An electronic structure and molecular dynamics software package - Quickstep: Efficient and accurate electronic structure calculations. The Journal of Chemical Physics, 152(19), 194103. https://doi.org/10.1063/5.0007045
  • LaFerla, F. M., Green, K. N., & Oddo, S. (2007). Intracellular amyloid-beta in Alzheimer's disease . Nature Reviews. Neuroscience, 8(7), 499–509. https://doi.org/10.1038/nrn2168
  • Lasagna-Reeves, C., Gonzalez-Romero, D., Barria, M. A., Olmedo, I., Clos, A., Sadagopa Ramanujam, V. M., Urayama, A., Vergara, L., Kogan, M. J., & Soto, C. (2010). Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochemical and Biophysical Research Communications, 393(4), 649–655. https://doi.org/10.1016/j.bbrc.2010.02.046
  • Lau, D., Jian, W., Yu, Z., & Hui, D. (2018). Nano-engineering of construction materials using molecular dynamics simulations: Prospects and challenges. Composites Part B: Engineering, 143, 282–291. https://doi.org/10.1016/j.compositesb.2018.01.014
  • Lee, C., & Ham, S. (2011). Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water . Journal of Computational Chemistry, 32(2), 349–355. https://doi.org/10.1002/jcc.21628
  • Lemkul, J. A., & Bevan, D. R. (2010). Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics. The Journal of Physical Chemistry. B, 114(4), 1652–1660. https://doi.org/10.1021/jp9110794
  • Lobanov, M. Y., Bogatyreva, N., & Galzitskaya, O. (2008). Radius of gyration as an indicator of protein structure compactness. Molecular Biology, 42(4), 623–628. https://doi.org/10.1134/S0026893308040195
  • Maleki, R., Khedri, M., Malekahmadi, D., Mohaghegh, S., Jahromi, A. M., & Shahbazi, M.-A. (2021). Simultaneous doxorubicin encapsulation and in-situ microfluidic micellization of bio-targeted polymeric nanohybrids using dichalcogenide monolayers: A molecular in-silico study. Materials Today Communications, 26, 101948. https://doi.org/10.1016/j.mtcomm.2020.101948
  • Maleki, R., Khedri, M., Rezvantalab, S., Afsharchi, F., Musaie, K., Shafiee, S., & Shahbazi, M.-A. (2021). β‐Amyloid targeting with two‐dimensional covalent organic frameworks: Multi‐scale in‐silico dissection of nano‐biointerface. Chembiochem : A European Journal of Chemical Biology, 22(13), 2306–2318. https://doi.org/10.1002/cbic.202100075
  • Malik, G. A., & Robertson, N. P. (2017). Treatments in Alzheimer's disease. Journal of Neurology, 264(2), 416–418. https://doi.org/10.1007/s00415-017-8395-1
  • Matubayasi, N. (2017). Free-energy analysis of protein solvation with all-atom molecular dynamics simulation combined with a theory of solutions. Current Opinion in Structural Biology, 43, 45–54. https://doi.org/10.1016/j.sbi.2016.10.005
  • Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G. (2009). Reviews: Current concepts in Alzheimer's disease: A multidisciplinary review. American Journal of Alzheimer's Disease & Other Dementias®, 24(2), 95–121. https://doi.org/10.1177/1533317508328602
  • Moon, M. (2016). The MIND Diet: A scientific approach to enhancing brain function and helping prevent Alzheimer's and dementia. Simon and Schuster.
  • Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., Ma, B., Nussinov, R., Najafi, S., Ngo, S. T., Loquet, A., Chiricotto, M., Ganguly, P., McCarty, J., Li, M. S., … Derreumaux, P. (2021). Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis. Chemical Reviews, 121(4), 2545–2647. https://doi.org/10.1021/acs.chemrev.0c01122
  • Ostrowitzki, S., Lasser, R. A., Dorflinger, E., Scheltens, P., Barkhof, F., Nikolcheva, T., Ashford, E., Retout, S., Hofmann, C., Delmar, P., Klein, G., Andjelkovic, M., Dubois, B., Boada, M., Blennow, K., Santarelli, L., & Fontoura, P. (2017). A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease. Alzheimer's Research & Therapy, 9(1), 95 https://doi.org/10.1186/s13195-017-0318-y
  • Perricone, U., Gulotta, M. R., Lombino, J., Parrino, B., Cascioferro, S., Diana, P., Cirrincione, G., & Padova, A. (2018). An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge. MedChemComm, 9(6), 920–936. https://doi.org/10.1039/c8md00166a
  • Pitschke, M., Prior, R., Haupt, M., & Riesner, D. (1998). Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy. Nature Medicine, 4(7), 832–834. https://doi.org/10.1038/nm0798-832
  • Quezada, G. R., Rozas, R. E., & Toledo, P. G. (2019). Ab initio calculations of partial charges at kaolinite edge sites and molecular dynamics simulations of cation adsorption in saline solutions at and above the pH of zero charge. The Journal of Physical Chemistry C, 123(37), 22971–22980. https://doi.org/10.1021/acs.jpcc.9b05339
  • Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. C., … Brashear, H. R. (2014). Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. The New England Journal of Medicine, 370(4), 322–333. https://doi.org/10.1056/NEJMoa1304839
  • Sun, Y., Xi, W., & Wei, G. (2015). Atomic-level study of the effects of O4 molecules on the structural properties of protofibrillar Aβ trimer: β-sheet stabilization, salt bridge protection, and binding mechanism. The Journal of Physical Chemistry. B, 119(7), 2786–2794. https://doi.org/10.1021/jp508122t
  • Takahashi, T., & Mihara, H. (2008). Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Accounts of Chemical Research, 41(10), 1309–1318. https://doi.org/10.1021/ar8000475
  • Tan, C., Cao, X., Wu, X.-J., He, Q., Yang, J., Zhang, X., Chen, J., Zhao, W., Han, S., Nam, G.-H., Sindoro, M., & Zhang, H. (2017). Recent advances in ultrathin two-dimensional nanomaterials. Chemical Reviews, 117(9), 6225–6331. https://doi.org/10.1021/acs.chemrev.6b00558
  • Tay, W. M., Huang, D., Rosenberry, T. L., & Paravastu, A. K. (2013). The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization . Journal of Molecular Biology, 425(14), 2494–2508. https://doi.org/10.1016/j.jmb.2013.04.003
  • Thijssen, E. H., Verberk, I. M. W., Vanbrabant, J., Koelewijn, A., Heijst, H., Scheltens, P., van der Flier, W., Vanderstichele, H., Stoops, E., & Teunissen, C. E. (2021). Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer's disease. Scientific Reports, 11(1), 9710–9736. https://doi.org/10.1038/s41598-021-89004-x
  • Xiao, Y., Ma, B., McElheny, D., Parthasarathy, S., Long, F., Hoshi, M., Nussinov, R., & Ishii, Y. (2015). Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease . Nature Structural & Molecular Biology, 22(6), 499–505. https://doi.org/10.1038/nsmb.2991
  • Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019). Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials, 224, 119491. https://doi.org/10.1016/j.biomaterials.2019.119491

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.